Stockscreener 앱 받기
2.68
2.68%
0.07
전일 마감가:
$2.61
열려 있는:
$2.61
하루 거래량:
18,501
Relative Volume:
0.22
시가총액:
$4.09M
수익:
-
순이익/손실:
$-23.14M
주가수익비율:
-2.6453
EPS:
-1.0131
순현금흐름:
$-29.23M
1주 성능:
+17.54%
1개월 성능:
+72.90%
6개월 성능:
-63.17%
1년 성능:
-81.44%
1일 변동 폭
$2.56
$2.68
1주일 범위
$2.15
$2.70
52주 변동 폭
$1.5004
$22.06
BiomX Inc Stock (PHGE) Company Profile
명칭
BiomX Inc
전화
972 7 23942377
주소
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
PHGE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
2.68 | 3.98M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-15 | 개시 | Ladenburg Thalmann | Buy |
BiomX Inc 주식(PHGE)의 최신 뉴스
Aug Retail: Will BiomX Inc outperform its industry peersWeekly Investment Summary & Reliable Price Breakout Signals - baoquankhu1.vn
BiomX appoints Reuven Yeganeh as director and issues Series Y preferred stock - Investing.com
BiomX appoints Reuven Yeganeh as director and issues Series Y preferred stock By Investing.com - Investing.com South Africa
BiomX Inc. Appoints Reuven Yeganeh as Class 1 Director, Effective December 19, 2025 - marketscreener.com
BiomX (NYSE: PHGE) closes placement, issues Series Y preferred shares - Stock Titan
Fund Flows: Can BiomX Inc stock double in the next yearQuarterly Performance Summary & Consistent Profit Trade Alerts - baoquankhu1.vn
How interest rate cuts could boost BiomX Inc. stockWeekly Trading Summary & Community Consensus Trade Alerts - Улправда
Is BiomX Inc. stock oversold or undervaluedCPI Data & Technical Entry and Exit Alerts - Улправда
Is BiomX Inc. stock dividend yield sustainableMarket Weekly Review & High Conviction Buy Zone Alerts - Улправда
Is BiomX Inc. stock resilient to inflationNew Guidance & AI Based Buy and Sell Signals - Улправда
Is BiomX Inc. stock ready for breakoutProtective Put Strategies & Free Dynamic Profit Opportunities - Улправда
BiomX announces new preferred stock financing and warrants - MSN
Chart Watch: Will BiomX Inc stock sustain uptrend momentum2025 Key Lessons & Reliable Entry Point Trade Alerts - moha.gov.vn
Growth Report: Is BiomX Inc stock recession proofJuly 2025 EndofMonth & High Win Rate Trade Tips - moha.gov.vn
BiomX announces $3M private placement - MSN
All you need to know about BiomX (PHGE) rating upgrade to buy - MSN
BiomX Announces $3.0 Million Private Placement - The Globe and Mail
BiomX Announces New Preferred Stock Financing and Warrants - TipRanks
BiomX Signs Multiple Material Agreements - TradingView — Track All Markets
All You Need to Know About BiomX (PHGE) Rating Upgrade to Buy - Yahoo Finance
BiomX (PHGE) Secures $3M Through Private Investment Initiative - GuruFocus
RSI Suggests Rebound May Be Near in Shree Cement LimitedCash Flow Trends & Free Dynamic Profit Opportunities - earlytimes.in
Is BiomX Inc. stock a buy before product launchesJobs Report & Target Return Focused Stock Picks - DonanımHaber
Is BiomX Inc. stock recession proofEarnings Growth Report & Consistent Growth Stock Picks - DonanımHaber
Will BiomX Inc. stock outperform foreign stocksJuly 2025 Reactions & High Win Rate Trade Alerts - DonanımHaber
BiomX (NYSEAMERICAN:PHGE) Shares Up 9.9% – Still a Buy? - Defense World
What risks investors should watch in BiomX Inc. stockPortfolio Risk Report & AI Enhanced Trading Alerts - DonanımHaber
Market Rankings: Can BiomX Inc. stock reach $100 price targetJuly 2025 EndofMonth & Safe Entry Zone Tips - Улправда
BiomX collapses into court proceedings after clinical trial fails - CTech
BIOMX INCDECISION FOLLOWS SAFETY REVIEW BY INDEPENDENT DMC - 富途牛牛
BiomX Discontinues Study and Files for Insolvency - TipRanks
BiomX Inc. Discontinues Phase 2b Study and Initiates Insolvency Proceedings - TradingView — Track All Markets
BiomX (NYSE: PHGE) subsidiary seeks insolvency as Phase 2b study ends, BX011 program retained - Stock Titan
BiomX Discontinues Phase 2b Trial for BX004 - The Globe and Mail
Earnings Beat: Is BiomX Inc stock oversold or undervaluedJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - moha.gov.vn
Healthy Upside Potential: BiomX Inc (PHGE) - setenews.com
BiomX Halts Phase 2b Trial Of BX004 In Cystic Fibrosis On High Rates Of Adverse Events - Nasdaq
Stocks Tumble As Bad News Hits Biotech And Energy Sectors - Finimize
BiomX Discontinues Phase 2b Clinical Trial for BX004 - TradingView — Track All Markets
BiomX (PHGE) Halts Phase 2b Trial and Implements Cost-Saving Str - GuruFocus
BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review - The Manila Times
BiomX announces discontinuation of phase 2b Bx004 trial following internal review - marketscreener.com
BiomX (PHGE) Price Target Increased by 964.52% to 168.30 - Nasdaq
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
BiomX (PHGE) Stock Analysis Report | Financials & Insights - Benzinga
Why BiomX Inc. stock could be top winner2025 Volatility Report & Precise Swing Trade Entry Alerts - Newser
How BiomX Inc. stock performs in high volatility marketsJuly 2025 Update & Daily Price Action Insights - Newser
BiomX Is Targeting the Infection Threat Returning to Modern WarAnd the Military Is Paying Attention (NYSE: PHGE) - markets.businessinsider.com
How BiomX Inc. stock reacts to Fed tighteningJuly 2025 Update & AI Forecasted Entry/Exit Points - Newser
BiomX Inc (PHGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):